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ABSTRACT Structural analysis of an acetylcholine receptor from Torpedo californica leads to a three-dimensional
model in which a "monomeric" receptor is shown to contain subunits arranged around a central ionophoretic channel,
which in turn traverses the entire 1 10 A length of the molecule. The receptor extends - 15 A on the cytoplasmic side, 55
A on the synaptic side of the membrane. The a-bungarotoxin/agonist binding site is found to be -55 A from the
entrance to the central gated ion channel. A hypothesis for the mechanism of AcChR is presented which takes into
account the structural and kinetic data, which is
agonist-induced structure change in AcChR.
INTRODUCTION
The release of neurotransmitters from nerve terminals
induces a selective increase in permeability to cations and
subsequent depolarization of the electric potential across
the postsynaptic membrane. This excitable membrane has
been extensively characterized at the electrophysiological,
cellular, kinetic, biochemical, and structural levels. Most
such characterization pertains to nicotinic receptors for
acetylcholine (AcCh) in vertebrate neuromuscular junc-
tions and in the electrocytes of Torpedo (a marine elasmo-
branch) or Electrophorus (a fresh water teleost) (reviews,
1-4).
We present here our recent results on the structural
analysis of acetylcholine receptor (AcChR) in Torpedo
californica electrocyte membranes. These and related
results are discussed with reference to possible mechanistic
consequences, focusing on a testable hypothesis for
AcChR action.
AcChR-rich membrane fractions are routinely obtained
by differential centrifugation of homogenized electric
organ and subsequent separation on density gradients (5).
Radioactively labeled neurotoxins such as a-bungarotoxin,
which bind extremely tightly but noncovalently to AcChR
with dissociation constants in the range 10-' -10-' M at
room temperature (6, 7), serve as a marker through the
isolation procedure; agonist-dependent cation flux can be
measured for microsac preparations to ensure functional
integrity of AcChR in vitro (8, 9). Under reducing condi-
tions SDS polyacrylamide gel electrophoresis of such prep-
arations shows six major bands with apparent mol wts of
40,000 (a), 43,000, 50,000 (d), 60,000 (y), 65,000 (6), and
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testable, and which serves as a focus for future studies on the
90,000 (10). Exposure to pH 11 for 1 h at 200C removes
the 43,000 and 90,000 mol wt polypeptides from the
AcChR-rich membranes without loss of agonist induced
fluxing ability (10, 11). These chains are therefore
presumed to be peripheral membrane proteins. Function-
ally intact AcChR vesicles which contain only a, fp, y, and
6 subunit types have been reconstituted from AcChR
either solubilized in octylglucoside (12) or in the presence
of exogenous lipids and cholate (13, 14). The subunit
composition of monomeric AcChR has been established
independently in several laboratories ( 15, 16) and found to
be a2f3-y6.' In vivo, however, AcChR occurs as a dimer
cross-linked via a disulfide between 6 subunits (17, 18),
though both the monomeric and dimeric forms show
identical ligand binding affinity and are equally active in
22Na-flux assays (19). Thus, the physiological relevance of
dimerization is as yet unidentified.
Evidence in favor of discrete ionophoretic channels in
the postsynaptic membrane was first obtained from the
noise-analysis of agonist-induced current fluctuations
measured for motor endplates under voltage-clamp condi-
tions (20, 21). More recently, with improved techniques
elementary single channel events have been directly
observed as all-or-none, rectangular, pulse-like wave forms
of constant amplitude (22). Agonist, temperature, and
membrane potential determine the average channel life-
time to be typically 1-3 ms. At 200C - I04 Na+ ions flow
into the cell during the opening of a single channel,
induced by the binding of AcCh. The ionophoretic
channel conducts ions as large as dimethyldiethanolam-
monium and must therefore be at least 6.5 A Diam (23)
throughout its entire length in the "open channel" state.
'First proposed by Reynolds and Karlin (47).
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Which subunit contains the agonist binding site and
therefore acts as the primary effector of the protein
conformational change associated with the opening of the
transmembrane channel? Using a variety of affinity labels
and neurotoxins, the AcChR agonist (or antagonist) bind-
ing sites have been located on the two a subunits (review,
4). Following reduction with dithiothreitol, one a subunit
of the T. californica AcChR can be affinity labeled with
4-(N-maleimido)-benzyltrimethyl-ammonium (MBTA)
or with bromoacetylcholine (BAC), either of which react
covalently with a single sulfhydryl and block 50% of the
available toxin binding sites (24, 25). Delegeane and
McNamee (26) claim that after one AcCh site is blocked
by alkylation with MBTA 22Na-flux is still induced by
binding of carbamylcholine to the second site. However
Lindstrom et al. (14) showed, using reconstituted AcChR
vesicles, that alkylation with MBTA in fact removed all
agonist dependent fluxing ability. Both results indicate
that ligand binding to one particular a-subunit (and not
the other) leads to channel opening. In unmodified AcChR
it is possible that agonist binding to both sites is more
effective than simply to the one site (27). The Hill coeffi-
cient for agonist-induced ion permeability response is
1.97 ± 0.062 thus two agonists are required for activa-
tion.3 4
AcCHR IS FUNNEL-SHAPED: ALL
SUBUNITS SPAN THE BILAYER
The transmembrane nature of the AcChR complex has
been independently demonstrated by x-ray diffraction
studies and by use of analytical probes such as proteases or
anti-AcChR-specific antibodies. Analysis of continuous
x-ray scattering profiles recorded from pellets of AcChR-
rich membrane preparations revealed an asymmetric
distribution of protein perpendicular to the lipid bilayer,
and showed that the protein extends 55 A on one side of
the membrane and 15 A on the other (28). In conjunction
with the in-plane dimensions of AcChR from electron
microscopy and the measured density of receptors per unit
area, this analysis provided a low-resolution, cylindrically
averaged structure of AcChR (29).
A sharp reflection of spacing 5.1 A is oriented exclu-
sively perpendicular to the membrane plane. This is the
expected angle for scattering from a-helices alone, and
2Neubig R. R., and J. B. Cohen. 1980. Permeability control by choliner-
gic receptors in Torpedo postsynaptic membranes. Agonist dose-response
relations measured at second and millisecond time scales. Biochemistry.
19:2770-2779.
3Cash D. J., and G. P. Hess. 1980. Molecular mechanisms of acetylcho-
line receptor-controlled ion translocation across cell membranes. Proc.
Natl. Acad. Sci. U.S.A. 77:842-846.
4Sine S. M., P. Taylor. 1980. The relationship between agonist occupa-
tion and the permeability response of the cholinergic receptor revealed by
bound cobra a-toxin. J. Biol. Chem. 255:10144-10156.
circular dichroism suggests that 34% of AcChR is a-
helical (30). The sharpness of the x-ray reflection indicates
that the a-helices in AcChR are on average 80 A long; its
orientation implies that essentially all a-helices are almost
perpendicular to the membrane, and this is strong evidence
that some (at least two) or all of the subunits are
themselves elongated perpendicular to the membrane
plane.
The funnel-shaped structure of AcChR is directly
visualized in side view by negative stain electron micros-
copy at the edge of a folded-over membrane vesicle (Fig.
1). Proof that these structures are membrane-bound
AcChR oligomers was obtained by immuno-electron
microscopy, since we were able to label them with anti-
AcChR antibodies coupled to -200 A-sized colloidal gold
spheres (29). Furthermore, experiments in which AcChR
was treated first with a-bungarotoxin and then with anti-
toxin antibodies attached to gold beads established that
the protein protrusion of 55 A was on the extracellular,
i.e., synaptic, side of the membrane. The smaller protru-
sion on the cytoplasmic surface was more difficult to
visualize by electron microscopy. However, as membranes
dry down onto the carbon support film, folds are often
formed. A small portion of these are sharp, and unambigu-
ously show the extracellular 55 A protrusion of AcChR
molecules on the outer surface of the folded double
membrane (Fig. 2). The minimum overall width of such
folded double membranes measures -200 A, close to twice
the 110 A length of the AcChR oligomer determined by
x-ray diffraction analysis (slight shrinkage is likely to be
associated with specimen dehydration for electron micros-
copy). The central double bilayer thickness averages 86 A.
As this value is close to twice the 40 A thickness of the
single bilayer (28), there must be little of the protein
protruding from the cytoplasmic surface. This observation
is in agreement with the asymmetric protein profile
computed from the x-ray diffraction data. The transmem-
brane nature of AcChR has further been demonstrated by
immuno-electron microscopy: antibodies raised against
solubilized AcChR and coupled with ferritin bind to both
the synaptic and the cytoplasmic sides of open membrane
vesicles (31, 32).
We now ask whether all five subunits span the bilayer or
whether there are components which are entirely buried in
the membrane while others are accessible from one side
only. As each subunit type present in membrane-bound
AcChR is accessible to degradation by exogenous
proteases (33-35) they must all protrude into the aqueous
phase and none is entirely buried within the lipid bilayer.
This conclusion is further substantiated by the finding that
all four subunit species can be iodinated in the presence of
lactoperoxidase (36). The fact that all subunits naturally
occur in their glycosylated form implies their exposure on
the synaptic membrane side (37, 38). Photoactivable
reagents that partition into the lipid phase of the
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BFIGURE 1 View of a uranyl acetate-stained synaptic edge of AcChR membrane vesicle (A) and schematic representation of the 55 A-long
funnel-shaped protrusions of the receptor molecules (B). The central channel is filled with uranyl stain down to at least the level of the lipid
bilayer. Modified from Fig. 4 in reference 29.
membrane label at least the /3, -y (39) and the a subunits
(40); therefore, an exclusively peripheral location of these
(and probably all) subunits is excluded. Combination
labeling and proteolysis showed the transmembrane
nature of the 40, 50 and 66 kilodalton chains in T.
marmarota.' Recently, Strader and Raftery (35) demon-
strated that all AcChR subunit types can be proteolyti-
cally cleaved from both the cytoplasmic and from the
synaptic side of the membrane. Thus current evidence
shows that all five subunits are elongated perpendicular to
the membrane, are in contact with the lipids for part of
their length, and protrude on both sides of the bilayer.
PROOF THAT EACH AcCHR MONOMER IS
A SINGLE INFUNDIBULIFORM
STRUCTURE
Electron micrographs of negatively stained AcChR
membranes (Fig. 3 A) reveal "rosette" structures 85 A
5Wennogle L. P., J-P Changeux. 1980. Transmembrane ?????????? of
proteins present in acetylcholine receptor-rich membranes from Torpedo
marmorata studied by selective proteolysis. Eur. J. Biochem. 106:381-
393.
Diam dispersed in the plane of the membranes (29,
41-44). Each rosette is a projection perpendicular to the
membrane surface of a single funnel-shaped structure.
AcChR occurs in vivo as dimers of the five subunit
complex; however, until recently direct evidence on
whether the infundibuliform structure corresponds to a
monomeric or dimeric receptor complex has been lacking.
Standard membrane preparations rich in monomeric or
dimeric AcChR appear indistinguishable from each other
because the molecules are so closely packed together.
Membranes reconstituted from exogenous lipid and solu-
bilized AcChR that was predominantly dimeric (79% by
integration of stained bands on SDS gels) revealed rosettes
spaced much further apart: 69% of the rosettes are seen to
be dimerized and 31% are single rosettes (total counted,
690). In a second approach, excessively base-treated (pH
11.5 for 1 h at 200C) and sonicated membranes from the
same source (79% dimeric) also led to a portion of
membranes with more dispersed AcChR mol (Fig. 3 B). In
this case, 78% of rosettes were in pairs, 22% were single
(total counted, 803). This unambiguously shows that each
infundibuliform structure is one AcChR monomer. This
same conclusion which we deduced in reference 28 and 29




FIGURE 2 Folds of a negatively stained (uranyl acetate), synaptic side-out vesicle (A, B) show the two lipid bilayers in close apposition on
the cytoplasmic side as depicted in cross section as if cut vertically between pairs of arrows shown (C). Arrows indicate regions of sharp bends
of the kind where distances between protrusions and the width of the double bilayer were measured.
has been drawn from dimer-reconstituted membranes
(45)6 and for solubilised AcChR dimer (34).7
EACH MONOMER CONTAINS A 1 io-A
LONG CENTRAL TRANSMEMBRANE
IONOPHORETIC CHANNEL
The centers of the rosettes generally appear more heavily
stained relative to membrane regions between AcChR
mol. However, quantitative analysis of the depth to which
the central well is stained relative to surrounding protein-
free membrane requires dispersed molecules as described
in the previous section. Furthermore, since the well
narrows to < 10 A, the analysis must be carried out at high
resolution, i.e., > 10 A resolution. Image reconstructions
of crystalline arrays (see below) cannot be used for such
purposes because disorder in the lattice limits the resolu-
tion to about 20-30 A. Thus, electron micrographs of
membranes with widely dispersed receptor molecules, such
6Cartaud J., J-L. Popot, and J-P Changeux. 1980. Light and heavy forms
of the acetylcholine receptor from Torpedo marmorata electric organ.
Fed. Eur. Biochem Soc. 121:327-332.
'Wise, D. S., B. P. Schoenborn, and A. Karlin. 1981. Structure of
acetylcholine receptor dimer determined by neutron scattering and
electron microscopy. J. Biol. Chem. 256:4124-4126.
as those shown in Fig. 3 B, were densitometered with a
raster size equivalent to 2.4 A. Optical densities (ODs)
were averaged over 3 x 3 arrays of picture elements and
overall OD distributions in stain-excluding protein regions
(OD = 1.84 ± 0.01), in protein-free membrane areas (OD
= 1.62 ± 0.01), and in the stain penetrated depressions
(OD = 1.48 ± 0.06), are displayed in Fig. 4. OD on the
film is linearly related to stain thickness in the sample.
Arbitrarily setting stain thickness of the protein stain-
excluding region to 0 A, the stain thickness of the
membrane bilayer region must then be 70 A (total recep-
tor height = 110 A; bilayer thickness = 40 A). Hence the
stain thickness of the central depression can be determined
by an extrapolation of a plot of mean regional OD vs. the
known relative stain thicknesses. From this extrapolation
we obtain the result that the central depression stain
thickness is 114 ± 19 A. This means that stain penetrates
throughout the entire transmembrane length of the recep-
tor at a single central ion channel under these conditions.
A THREE-DIMENSIONAL MODEL OF
AcCHR
We have analyzed the structure of AcChR by optical and
computer filtration of two forms of crystalline membrane-
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FIGURE 3 Uranyl acetate-stained AcChR membrane sheets derived from preparations rich in dimeric AcChR. In a portion of the
membranes the densely packed AcChR molecules (A) have been dispersed by excessive base treatment and sonication (B). Circles outline
some of the dimeric pairs of AcChR in the membrane.
0
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FIGURE 4 Distribution of optical densities for the stain (uranyl acetate)-
filled depression of AcChR molecules (left), for protein-free membrane
regions (40-A stain excluding thickness, middle) and for the stain-
excluding protein protrusion of AcChR (mean stain-excluding thickness
110-A, right). From this graph the stain depth in the center of the
infundibuliform AcChR molecule is calculated to be 114 + 19 A. The
error is based on variance in AOD between individual AcChR crest and
central well OD and on variance of their average values.
bound AcChR: large membrane sheets (28), and
membrane tubes (45). Whereas planar crystalline arrays
occur only rarely in fresh AcChR membrane preparations,
ordered synaptic side out, tubular arrays are formed
spontaneously at 40C upon annealing over a period of six
weeks or longer. No proteolytic degradation was observed
after much longer periods under the same conditions, and
the tubes were shown to contain all four subunit types of
AcChR by immuno-electron microscopy (45). These
structures present many differently angled views of
AcChR, which resolve into the characteristic infundibuli-
form shape -doublets with 55 A protrusion- at the edge
(Fig. 5 A). Computer filtrations, viewed from the cytoplas-
mic surface of the membrane (Fig. 5 B), uniformly show a
characteristic arrangement of two large peaks, one smaller
peak, and a deep groove, always in the same sequence in
the anticlockwise direction, and around the central iono-
phoretic channel. A three-dimensional model based on the
scaled contour heights in filtered images and the electron
density determined by x-ray analysis is shown in Fig. 6.
With the partial specific volume of 0.74 cm3 gm-' calcu-
lated from the amino acid composition of AcChR (46), the
total volume of the model would correspond to a total mol
wt of 277,000 + 5,000. This is somewhat larger than the
measured value of Reynolds and Karlin (47) of 250,000,
and the radius of gyration computed from the model is 43
A which is slightly smaller than the value 46 ± 1 A
measured by Wise et al. (48) using neutron diffraction.
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FIGURE 5 Membrane tubes with a crystalline surface lattice of AcChR oligomers spontaneously anneal from AcChR membrane vesicles. In
a negatively stained specimen both sides of the flattened tube are visualized superimposed (A) but can be separated by computer filtering (B).
Two major and a minor protein peak and a stain-filled groove always surround the central depression in the anticlockwise sense viewed from
the cytoplasmic side (uranyl acetate stained).
In the model the individual elongated subunits must be
arranged around the central channel much as five staves of
a barrel. Tentative location of the subunits within the
model at this stage is based on our preliminary cross-
linking studies, on peak heights in the model, and on the
ratios of subunit molecular weights.
NEUROTOXINS AS PROBES FOR THE
AGONIST BINDING SITE
The dissociation constant for AcCh to AcChR is 10-' M
and binding is competitive with curare and curaremimetic
snake neurotoxins whose dissociation constants are three
to four orders of magnitude lower (49). The affinity label
MBTA competes stoichiometrically with both agonists
and neurotoxins (4), facts which strongly argue that toxin
and agonist binding sites on AcChR overlap. Using
sequence information available for a-bungarotoxin (50),
we detail current knowledge of this toxin-AcChR inter-
face, and the status of direct and indirect evidence that
this regulatory site is on the synaptic crest of AcChR, far
from the gated part of the channel.
The structure of a-bungarotoxin, determined by x-ray
crystallography (51; see reference 68),' reveals that this
8Agard, D. A., S. A. Spencer, and R. M. Stroud. Evolution of a molecular
surface interaction: the structure of a-bungarotoxin. Proc. Nati. Acad.
Sci. U.S.A. Submitted for publication.
toxin, like those of the evolutionarily-related erabutoxin b
(52-55) and a-cobratoxin (56), is a flat "hand-shaped"
molecule consisting of three disulfide cross-linked loops of
polypeptide chain. Chemical modification of its various
reactive amino acid side chains reduces, (but rarely abol-
ishes) its binding affinity to AcChR (57). The reactive
residues (with exception of Trp 29; see below) as well as
most of the evolutionarily conserved, titratable side chains
(50, 58) are dispersed on a 20 x 30 A area on the concave
surface of the molecule (see Fig. 7). Thus all current
evidence points to an extended toxin binding surface on the
AcChR, as Low suggests (53), rather than a single,
specific binding site.
Comparison of a-bungarotoxin with erabutoxin b shows
that the detailed secondary and tertiary structures are
different. Thus either or both would have to refold in
binding to AcChR to reach congruence for the positions of
the interface residues. For example, there are only four
inter-chain hydrogen bonds in a-bungarotoxin (Fig. 7),
whereas 70% of erabutoxin b is f: sheet. Furthermore, the
side chain of conserved Trp 29 must clearly lie in the
interface region. However, it is found on the opposite side
of the molecule in the two toxins. Thus, the toxins (and/or
the receptor) must refold upon binding as suggested by the
extremely slow association rates for "long" toxins t112 =
1-3 min (59) and the fact that association (but not











FIGURE 6 A three-dimensional model for the funnel-shaped AcChR molecule in the lipid bilayer. (A) On average 80 A-long a-helices
indicate an elongated shape of subunits which are arranged perpendicular to the membrane channel. The protein topography has been
inferred from the densities in computer filtered images of AcChR tubular lattices, from side views, and from x-ray diffraction. (B) AcChR
molecule viewed from the synaptic side with borders arbitrarily drawn between elongated subunits and tentative assignment of subunit types
consistent with our cross-linking data which show prominent a-y and -y4 linkages (disuccinimidyl tartarte, 6 A span). Karlin and colleagues
(Proc. Natl. Acad. Sci. U.S.A.; in press) have found an average angle of 1 130 + 330 between the two a subunits per monomer, in agreement
with our assignment.
Based on chemical modifications (53, 57), it has been
suggested that the side chains of Asp 31, Arg 37, Gly 38
probably occupy the acetylcholine binding site (53, 55).
However, unlike AcCh, the toxins do not lead to channel
opening. Could the extended binding interface serve to
"lock" the quaternary structure of AcChR?
a-Bungarotoxin binds on the outside of the 55 A portion
of AcChR on the synaptic membrane surface. This has
been directly visualized by electron microscopy of AcChR
membranes treated first with toxin and subsequently with
antitoxin antibodies coupled with gold beads (29). A more
precise localization of the bound toxin on the AcChR
molecule by electron microscopy and image processing of
AcChR arrays has not yet been possible as toxin binding
appears to destroy the lattices in membrane sheets or
tubes. However, available evidence strongly indicates that
the binding area of a-bungarotoxin is located on the top
synaptic crest of the AcChR oligomer. (a) X-ray diffrac-
tion from oriented pellets of conventionally prepared
AcChR membranes revealed orders of 300-370 A spacing
in the meridional direction, and in-plane near neighbor
distances of 91 ± 1 A (61). More recently, on alkali
stripped membranes (1 1), we have obtained x-ray diffrac-
tion patterns which reveal up to 11 orders of a 294 ± 5.5 A
lattice spacing between stacked vesicle membrane pairs,
and 90 A nearest-neighbor distance in the plane of the
membrane (Fig. 8 A). In toxin-treated samples, however,
the lattice spacing in both meridional and equatorial
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FIGURE 7 A schematic view of the amino acid sequence (50) and three
loop structure (51) of a-bungarotoxin. Residues which are highly
conserved among (a) all of the curaremimetic toxins, both "long" and
"short" are enclosed in solid circles; (b) all of the "long" toxins but not
between the long and the short are in dashed circles. Amino acids where
chemical modification of the side chain has been shown to affect toxicity
(53, 57) are indicated with a star; sites where an evolutionary change in
the sequence seems to be correlated with a change in toxicity are in solid
squares (53, 57). With exception of the four totally conserved cystine
bridges, no single invariant or conserved residue has been shown to be
essential for activity. It is therefore presumed that the residues contained
within square boxes, and those marked with a star are in some way
involved in the interface between a-bungarotoxin and AcChR, and all
such side chains except R26 and W29 lie on the concave surface from
which side the schematic is viewed. Dashed lines indicate hydrogen bonds
between main chain atoms, and thick solid lines indicate the structurally
important disulfide linkages.
directions changes, and ordering is diminished (Fig. 8 B).
This observation suggests a toxin site which affects both
in-plane neighbors and molecules in neighboring mem-
branes, i.e., a site on the outside upper crest of AcChR
(direct analysis of intensity (62) and electron density is in
progress). (b) This interpretation is also consistent with
our finding that membrane-bound AcChR preincubated
with a-bungarotoxin is much more rapidly digested to the
27,000-mol wt limit digest pattern by trypsin (33) than
AcChR in untreated membranes. (c) Antibodies raised
against curaremimetic neurotoxins (i.e., most probably
against toxin-host AcChR complex) have had specificities
mapped onto the sequence, (63, 64) and hence into the
structures of the toxins (56). Essentially all of the anti-
genic sites are located on the "back" convex surface which
is not involved in the interface with AcChR. Furthermore,
antitoxin antibodies bind to the toxin-AcChR complex
(29). This implies that the toxin, and hence agonist,
binding site is peripheral and not buried in the ionophor-
etic channel.
We conclude that the acetylcholine binding site is
located within the toxin binding area, on the synaptic
crest, and -55 A from the entrance to the most constricted
region of the ionophoretic channel.
A FUNCTIONAL MODEL FOR ACCHR
The large distance between ligand site and the entrance to
the ion channel (which must be the gated channel), - 55 A,
raises questions as to how the binding of acetylcholine can
lead to opening of an an ion channel. The mechanism
could fall into either of two classes: the effect of acetyl-
choline could either be communicated to the channel by a
detailed relay of coupled side chain motions, focusing the
allosteric effect to a critical gate within the channel, or it
could involve a large "global" change in conformation
induced in the oligomer by ligand binding. Several factors
strongly suggest the second kind of mechanism, that the
conformation changes involved in channel opening, chan-
nel closing, and desensitization are large. Firstly, the
reactivity of three out of four types of receptor subunits to
photolabeling by bisazidoethidium bromide is altered by
ligand binding (65). Secondly, antisera have been
prepared which can inhibit channel opening without
affecting ligand binding (66). Can they, like neurotoxins
perhaps, "lock" the quaternary structure and therefore
prevent the necessary large quaternary change? Thirdly,
AcChR binds -16 terbium ions of which half can be
displaced by ligand binding (67). Again, the suggestion is
for a large configurational change of the molecule. The
channel itself must be large, at least 6.5 A across, yet must
present a large energy barrier to the passage of ions in the
closed state. It is difficult to imagine how any small
configurational changes, say swinging of a tyrosine side
chain at the end of an allosteric relay, could regulate such
large changes in the free energy barrier to ion permeabili-
ty. Thus we contend that the cited evidence strongly
supports a mechanism which involves a global change
between the closed channel state and the ligand-induced
open channel state.
We now propose a testable hypothesis for the mecha-
nism of AcChR (see Fig. 9 and reference 68). We postu-
late that binding of agonist changes the quaternary state
from one stable resting or closed state, via an open channel
state, to a second stable, closed state that is quite different
from the first, although it has essentially the same ground
state free energy. This kind of mechanism can satisfyingly
explain many properties of the ligand-induced channel
opening events. We postulate that one subunit, a,, is in a
"primed" state (a,'), different from that of the other (a2).
Ligand binding to both subunits together (Fig. 9 i), leads
to channel opening with a rate constant kj, represented in
Fig. 9 by alignment of the extended a-subunits around the









FIGURE 8 X-ray patterns recorded from alkali stripped membrane preparations. (A) Native membranes show 11 orders of an inter-vesicle
repeat spacing of 294 + 5.5 A throughout the pellet. A shorter exposure is shown in the right half of the panel, and spacings in A are indicated
parallel to the upper meridion. Even diffraction orders are much stronger than odd orders; 1 = 2,4,6,8 are most obvious in the figure. (B)
Membranes with a-bungarotoxin added show a dramatic change in both meridional and equatorial spacings and in the variation of these
spacings within the pellet. Spacings below the center of the figure identify the main, correspondingly broader reflections along the meridian.
a-subunit (a2) now reverts to a configuration similar to
that initially held by a, and so closes the channel with a
second rate constant k2. This closed quaternary state (Fig.
9 iii) is different from (Fig. 9 i), but also a stable closed
state. Acetylcholine can diffuse away from a, and a2
without evoking a microscopically-reversible, channel-
opening event. A concommitant relaxation allows the a2
subunit to resume a configuration like that previously held
by aI, (Fig. 9 iv).
The next event would first lead to channel opening (Fig.
9 v), then ultimately change the quaternary state (Fig. 9
vi) back to the initial a,', a2 state (Fig. 9 i). In this
mechanism the two possible open channel states are inter-
mediate states whose lifetimes are determined primarily
by the barrier to a change in the structure of agonist-
bound AcChR itself, and are therefore independent of
agonist concentration.
This proposal is a "cyclic" mechanism, and to close the
cycle the channel is opened twice. It takes account of the
evidence for a large conformational change in receptor and
the inherent asymmetry of ligand binding at the 2 a-
subunits. This proposal would also postulate that the
asymmetric MBTA binding site should change upon chan-
nel opening from one subunit a,', to the other, a2'. It could
explain how toxin or antisera binding can inhibit channel
opening by locking a more distant (-55 A from the
channel) global quaternary structure change. The hypoth-
esis also takes account of the fact that the channel does not
reopen upon dissociation of ligand in the microscopic
reverse of association. We present this idea as a means of
focusing the wealth of data now emerging on AcChR
structure. We also seek to define the respective subunit
locations in the molecule, to quantitate the motion of
subunit polypeptide chains, to define the ends of the 80 A
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FIGURE 9 Proposal for a cyclic mechanism of AcChR in which a major quaternary structure change between one resting or closed state (i),
and a second different resting state (iii), is triggered by agonist binding to both a subunits of which one is in primed configuration, and passes
through an open channel state (ii). The open state is closed primarily by the second a2-subunit (iii). The next event is triggered at the other a2'
subunit following a relaxation to a state in which a2' resembles the state previously held by a, (iv). A second open channel state (v) is probably
similar but not identical to the first, and it closes (vi) before relaxation to the original resting state which closes the cycle. Quaternary change
is indicated purely schematically as motion of one or other of the elongated a-subunits. Slow relaxations are indicated as changing shape of
the ligand binding site. In the desensitized states, (vii, viii) high affinity for ligand is represented by the most circular scheme for the agonist
binding site. Arrows pick out the main pathways in the cyclic scheme. Other homologous subunits are presumed to pack around the central
ion channel as indicated in (ii and v). Rough estimates of the rates (half-times) are indicated above major equilibria in the scheme. This
"mechanical" scheme is not a minimal scheme consistent with kinetic data.2'3
helices in the sequence using chemical labeling techniques,
and to determine the change in orientation within the
AcChR induced by ligand binding. In collaboration with
Dr. Jon Lindstrom and his colleagues we are attempting to
decline binding sites for monoclonal antibodies in the
AcChR, using tubular structures as described above.
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DISCUSSION
Session Chairman: Donald M. Engelman Scribe: Adam W. Dalziel
McNAMEE: You said that toxin appears to destroy the lattice organi-
zation. Do other ligands also destroy the lattice structure? For example,
it would be interesting to look at AChR with covalently-bound bromoace-
tylcholine.
STROUD: We don't know whether or not reagents such as bromoacetyl-
choline break up the lattice.
McNAMEE: If a fairly large conformational change is associated with
channel opening and desensitization, could you detect it?
STROUD: Yes, at 30-A resolution we can still hope to detect changes of
a much smaller distance. A difference Fourier transform map can detect
changes of 6 A at 30 A resolution. In collaboration with Sebastian
Doniach, Robert Fairclough, and Keith Hodgson, we have investigated
conformational change of the receptor using anomolous x-ray scattering
from Terbium ions. George Hess has showed that these ions bind to the
receptor but are removed by the binding of ligand.
McNAMEE: George Hess has presented a detailed kinetic scheme for
receptor-mediated ion flux based on initial rate studies in eel vesicles
(Hess et al. 1979. Nature [Lond.]. 282:329 -331). Your model is more
complex and more speculative. Have you tried to reconcile your model
with Hess's?
STROUD: Fig. 9 shows our proposal. It is not a minimal model for the
action of the receptor, but it was designed to deal with the question that if
ligand binding to the receptor leads to channel opening (in agreement
with the model of Hess, who has quantitated the rates of many of these
steps), why does ligand diffusing away not lead to channel opening again
in returning to the same starting structure? Channel opening is depen-
dent on agonist type and concentration, while channel closing is indepen-
dent of either. It therefore depends on the receptor complex. Our model is
a cyclic scheme; half of this model would almost be equivalent to Hess's
scheme. Mark McNamee and George Hess now have evidence for two
steps in the desensitization of torpedo receptor (Walker et al. 1981.
Biochem. Biophys. Res. Commun. 100:86 -98). One step is slow and one
is fast.
McNAMEE: Alkali extraction removes the 43,000-dalton protein. It has
been suggested that this protein is involved in receptor organization. Does
the 43,000-dalton protein have any effect on the lattices you obtain?
KISTLER: The tubes with the crystalline AChR arrangement can only
be obtained with preparations which have not been stripped with alkaline
pH and so the 43,000-dalton protein is present in the preparations.
However, we have not yet attempted to use anti-43K antibodies to
determine if the 43K protein is present in the tubes. If it is, then we would
presume that it is attached to the inside of the tubes since we know that
the tubes are oriented with the synaptic side out.
STROUD: EPR studies by Philippe Devaux on the stripped and
unstripped AChR membranes have been used to study the immobiliza-
tion of the AChR. Devaux showed that the presence of the 43K protein
leads to relative immobilization of the receptor.
EISENBERG: Why is it that the doublets in Fig. 3 are not seen in
projection in Fig. 1?
382 STRUCTURAL STUDIES
STROUD: Only recently has it been possible to visualize individual
dimers either by reconstitution (Sodel et al. 1980. Eur. J. Biochem.
110:13 -33), by studies by Karlin and on co-workers isolated molecules
(Karlin et al. 1980. Cold Spring Harbor Symp. Quant. Biol. 40:203 -
213), or by dispersing the AChR in the membrane by the technique
described in our paper. Previously it was not possible to get molecules far
enough apart to see individuals like that.
EISENBERG: In your paper you say that the apparently competitive
binding among AChR, curare, and neurotoxins argues strongly that toxin
and agonist-binding sites overlap. In fact, other (allosteric) mechanisms
could be invoked to explain such behavior, and indeed you later invoke
allosteric mechanisms themselves. But then, purely on the basis of
evidence for toxin location, you state that you have located the AChR
binding site. Aren't there gaps in the argument?
STROUD: Yes, there is the possibility that these sites do not overlap;
however, very few people accept this. The binding is strictly competitive
between these things: one will not bind while the other is there. Also the
arganine aspartate ion pair in some toxins has been proposed (by Barbara
Low) to mimic acetylcholine (Low et al. 1976. Proc. Natl. Acad. Sci.
U.S.A. 73:2991 -2994; Low et al. 1979. Handbook of Experimental
Psychology. 52:213 -257). In toxins which contain an asparagine instead
of the aspartate, toxin binding is impaired. Thus we conclude that the
binding sites overlap.
STEVENS: I am unconvinced by the claim in your paper's Discussion
that densitometric measurements from micrographs of negatively stained
specimens "unequivocally prove that stain penetrates throughout the
entire transmembrane length of the receptor at a single central ion
channel." This conclusion is based on several assumptions which are not
individually or collectively plausible. In essence, you are assuming that
the layer of stain and membrane material is uniformly 110-A thick with
the portion of stain being the complement of the membrane material. I
can think of no reason of principle or precedent for believing this to be the
case. A simple alternative explanation (and by no means the only
alternative), is that your darker centers could be accounted for by some
accumulation of stain above or below the rosette with relatively shallow
stain between rosettes. Further, there are dark patches visible in parts of
Fig. 3b which are not located at the centers of rosettes. Are these also ion
channels?
This leads to another question: Do you have any further evidence to
support the idea that it is possible to deduce a three-dimensional structure
unambiguously from a single two-dimensional projection?
KISTLER: Everybody who works with negatively-stained specimens for
electron microscopy knows that when you look over the grid at the whole
specimen there is a lot of stain variation. Also, it is important which side
of the specimen is in contact with the support film. In various cases
(especially with periodic arrays) the near side of the film is best preserved
and stained and has the most contrast.
With AChR membranes we are very fortunate. We adsorb vesicles to
a carbon film which had been rendered hydrophilic by glow discharge.
When the vesicles adsorb to the film they break open, especially with
alkaline-extracted membranes. The vesicles are synaptic side out, and
when they adsorb to the supporting film the side with the 50 A protrusion
is in contact with the support film. I am convinced that with a film made
hydrophilic by glow-discharge you will fill in the space in between with
stain. I acknowledge that this would not necessarily be the case if the
situation were reversed and the membrane was attached to the grid by
the cytoplasmic side. However, because we were fortunate in attaching
the membranes on the synaptic side, the stain layer is as thick as 1 10 A,
or at least 100 A if we give a little tolerance for the small 10 A protrusion
not being fully covered by stain on the cytoplasmic side. I am confident
that the stain thickness is, in fact, 110 A + 10 A.
STEVEN: I think that it is important to have something much more
quantitative.
GAFFNEY: It seems that some of these questions could be answered by
asking if any other cation's ligands compete with the uranyl stain. This
might determine whether the uranyl is in the channel or not.
KISTLER: We have asked ourselves why the uranyl would enter the
channels when we would expect them to be closed. The answer is we do
not know.
STROUD: We do know that phosphotungstic acid does not apparently
stain the channel so deeply. Also the electrophysiology has not been done
with uranyl ions.
GAFFNEY: Do you expect to be able to get evidence from EM pictures
for the proposal in Fig. 9 that an MBTA site can be located on either of
the a-subunits, for instance by two types of alteration of a structure
having particular handedness such as that shown in Fig. 5?
STROUD: This is something that Karlin and his colleagues have
contributed to by using an avidin coupling through biotin to neurotoxins
on the AChR in solubilized form. We have another approach to the
question whether the MBTA site is always on one a-subunit rather than
the other. It is known from Karlin and McNamee's work that one specific
a-subunit binds MBTA while the other a-subunit does not (Karlin et al.,
1975). McNamee has pointed out that the environment of each a subunit
in this complex is different. If any of the binding sites were close to
neighboring subunits they are intrinsically asymetric.
STEITZ: How might the AChR assemble so that one set of a-subunits
would interact only with a and ,3 while the other would interact with f3
and Ay? What prevents polymerization of different sorts?
STROUD: It has been shown that each molecule contains the same
combination of subunits. The sequence analysis shows that all the
subunits are homologous. We propose that these subunits are arranged
like five staves of a barrel and that these stave-like interactions specify
the general nature of the surrounding of the channel. Presumably some
other determinants of the sequence specify the nearest neighbors. Once
the assembly has started the system is asymetric. For example, an a-y
combination might have a unique structure which specifies its nearest
neighbors.
WOLBER: Are the two a-subunits orientated vectorially the same
way?
STROUD: Yes.
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